Skip to Main Content

Paper Details

Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers.
Brain Commun
44
2021
-, -amyloid40, -amyloid42, APOE, APOE 4, APOE genotype, Alzheimer's Disease, Alzheimer's disease, amyloid, amyloid40, amyloid42, cognitively impaired, mild cognitive impairment, neurofilament light, participants, phosphorylated-tau, plasma -, plasma phosphorylated-tau, threonine
Author NameAffiliation
Paul S AisenAlzheimer's Therapeutic Research Institute (ATRI), Keck School of Medicine, University of Southern California
Clifford R JackMayo Clinic
William J JagustSchool of Public Health and Helen Wills Neuroscience Institute, University of California berkeley
Ronald C PetersenMayo Clinic
Ronald C PetersenMayo Clinic
Andrew J SaykinCenter for Neuroimaging, Indiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Andrew J SaykinCenter for Neuroimaging, Indiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Leslie M ShawPerelman School of Medicine, University of Pennsylvania
John Q TrojanowskiPerelman School of Medicine, University of Pennsylvania
Michael W WeinerSan Francisco Veterans Affairs Medical Center
Michael W WeinerUniversity of California San Francisco
  • 1 - 15

Datasets

Release 1.2